See more : Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF) Income Statement Analysis – Financial Results
Complete financial analysis of HilleVax, Inc. (HLVX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HilleVax, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Mustang Energy PLC (MUST.L) Income Statement Analysis – Financial Results
- Aeon Delight Co., Ltd. (9787.T) Income Statement Analysis – Financial Results
- First National Bank Alaska (FBAK) Income Statement Analysis – Financial Results
- Stylam Industries Limited (STYLAMIND.BO) Income Statement Analysis – Financial Results
- Pickles Holdings Co.,Ltd. (2935.T) Income Statement Analysis – Financial Results
HilleVax, Inc. (HLVX)
About HilleVax, Inc.
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.16M | 2.25M | 3.00K | 0.00 | 0.00 |
| Gross Profit | -2.16M | -2.25M | -3.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 106.68M | 45.91M | 10.01M | 0.00 | 0.00 |
| General & Administrative | 26.66M | 16.71M | 5.76M | 1.30M | 633.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 632.37K |
| SG&A | 26.66M | 16.71M | 5.76M | 1.30M | 633.00K |
| Other Expenses | 0.00 | -94.70M | -20.23M | -779.00K | 0.00 |
| Operating Expenses | 133.35M | 62.61M | 15.77M | 1.30M | 633.00K |
| Cost & Expenses | 133.35M | 62.61M | 15.77M | 1.30M | 633.00K |
| Interest Income | 9.71M | 3.88M | 2.84K | 29.00 | 9.00 |
| Interest Expense | 2.39M | 3.41M | 2.84M | 29.00K | 9.00K |
| Depreciation & Amortization | 879.00K | 2.25M | 3.00K | 1.30M | 633.00K |
| EBITDA | -132.47M | -65.11M | -99.56M | -2.07M | -31.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -133.35M | -65.11M | -53.43M | -1.30M | -633.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.78M | -94.70M | -48.98M | -808.00K | -40.00K |
| Income Before Tax | -123.57M | -159.81M | -102.41M | -2.10M | -673.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 97.20M | -17.38M | 29.00K | -633.00 |
| Net Income | -123.57M | -257.01M | -85.03M | -2.13M | -673.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -3.04 | -6.83 | -2.82 | -0.07 | -0.02 |
| EPS Diluted | -3.04 | -6.83 | -2.82 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 40.60M | 37.66M | 30.19M | 30.19M | 30.19M |
| Weighted Avg Shares Out (Dil) | 40.60M | 37.66M | 30.19M | 30.19M | 30.19M |
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of HilleVax, Inc. ("HilleVax") (NASDAQ:HLVX) concerning possible violations of federal securities laws. On July 8, 2024, HilleVax was the...
The Schall Law Firm Invites HLVX Investors To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) for violations...
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of HilleVax, Inc. ("HilleVax") (NASDAQ:HLVX) concerning possible violations of federal securities laws. On July 8, 2024, HilleVax was the...
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK CITY, NY / ACCESSWIRE / July 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX). Investors who purchased HilleVax securities are encouraged to...
HLVX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by HilleVax, Inc.
NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of HilleVax, Inc. ("HilleVax") (NASDAQ:HLVX) concerning possible violations of federal securities laws. On July 8, 2024, HilleVax was the...
HLVX Investors Are Welcomed By The Schall Law Firm To Join Its Inquiry Into Suspected Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) for violations...
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK CITY, NY / ACCESSWIRE / July 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX). Investors who purchased HilleVax securities are encouraged to...
HilleVax, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - HLVX
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of HilleVax, Inc. ("HilleVax") (NASDAQ:HLVX) concerning possible violations of federal securities laws. On July 8, 2024, HilleVax was the...
The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) for violations...
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Shareholders to Contact the Firm!
NEW YORK CITY, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX). Investors who purchased HilleVax securities are encouraged to...
Source: https://incomestatements.info
Category: Stock Reports